IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: The highly fatal glioblastoma has an extremely poor prognosis and development of a new treatment is desired. Local treatment is limited due to its high invasiveness, and immunotherapy utilizing self-immune mechanism is theoretically expected. An autologous formalin-fixed tumor vaccine (A...

Full description

Saved in:
Bibliographic Details
Published in:Neurooncol Adv
Main Authors: Nitta, Masayuki, Muragaki, Yoshihiro, Ishikawa, Eiichi, Maruyama, Takashi, Ikuta, Soko, Saito, Taiichi, Tsuzuki, Shunsuke, Fukui, Atsushi, Mastumura, Akira, Kawamata, Takakazu
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213209/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.079
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items